URMC Investigating New Parkinson's Drug
The University of Rochester Medical Center Clinical Trials Coordination Center (CTCC) has been tapped to help lead a clinical trial for a potential new treatment for Parkinson ’s disease. The study will evaluate nilotinib, a drug currently used to treat leukemia that has shown promise in early studies in people with Parkinson’s disease.
Source: University of Rochester Medical Center Press Releases - Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news
More News: Clinical Trials | Leukemia | Nilotinib | Parkinson's Disease | Study | Tasigna | Universities & Medical Training